Equity Info – Page 382

Aurobindo Pharma Ltd (AUROPHARMA)

📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 1048.20
% Change: 0.60% (Prev Close: 1041.90)

Volume: 10,36,358
% Change: 149.27% (Prev Volume: 4,15,761)

Delivery: 6,10,814
Delivery % : 58.94
% Change: 274.73% (Prev Delivery: 1,63,001)

Turnover: 10,809 Lacs
% Change: 149.15% (Prev Turnover: 4,338)

💹 EOD Valuation

P/E Ratio: 18.11
P/B Ratio: 1.88
Market Cap: 61414 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: AUROPHARMA
Market Cap: 60229 Rs. Cr.
Face Value: 1.00 Rs.

52 Week High: 1592.55
52 Week Low: 994.35

All-Time High: 1592.55 Rs.
All-Time Low: 10.13 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-4.11% | -10.87% | -5.70% | -33.24% | 24.25%

👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 51.81%

Change (3Y | 1Y): -0.02% | -0.01%

Pledged %: 17.08%

FII Holding

FII Holding: 14.38%

Change (3Y | 1Y): -6.33% | -0.95%

DII Holding

DII Holding: 26.93%

Change (3Y | 1Y): 9.63% | 0.70%

Public Holding: 6.88%

🏦 Financial Strength

Debt to Equity: 0.25
Debt: 8262.87 Rs. Cr.

Book Value: 557.28 Rs.
Current Ratio: 1.85
Interest Coverage: 12.15
Free Cash Flow: 1407.91 Rs. Cr.

📈 Growth & Sales

Sales Growth: 7.76%

Sales Growth Qtr (YOY | QoQ):
3.98% | -6.13%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
6.55% | 10.59% | 7.76%

💰 Profit & Earnings

Profit Growth %

Profit Growth: -5.45%

Profit Growth Qtr (YOY | QoQ):
-10.28% | -8.71%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
3.87% | 7.90% | -5.45%

EPS Rs.

EPS (TTM): 57.88 Rs.

EPS Qtr (Last Year | Latest):
15.69 Rs. | 14.08 Rs.

EPS Annual (Last Annual | Annual March):
54.15 Rs. | 59.49 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
3.87% | 7.90%

Net Profit Rs. Cr.

Net Profit (TTM): 3389.55 Rs. Cr.

Net Profit (Annual - March): 3483.57 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
918.22| 902.83 | 824.20

EBITDA Rs. Cr.

EBITDA (Quarter): 1710.25 Rs. Cr.
EBITDA (Previous Yr Ql): 1839.11 Rs. Cr.

EBITDA (Annual - March): 7139.42 Rs. Cr.
EBITDA (Previous Annual): 6359.63 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
7.21% | 15.06%

📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 20.32%

OPM Qtr (Previous | Current):
20.99% | 20.37%

OPM Annual (5 Yrs | Last Yr | March):
19.25% | 20.09% | 20.65%

Return on Equity %

ROE: 11.08%

ROE (5 Yrs | 3 Yrs | Last Yr):
11.59% | 10.15% | 11.55%

Return on Capital Employed %

ROCE: 14.18%

ROCE (5 Yrs | 3 Yrs | Last Yr):
13.79% | 12.49% | 14.10%

Return on Assets %

ROA (TTM): 7.35%

ROA (5 Yrs | 3 Yrs | Last Yr):
7.91% | 6.79% | 7.76%

PEG Ratio: 2.25
Dividend Yield: 0.44%

PE 3 Yrs: 20.29
PE 5 Yrs: 17.22

Dividend Yield: 0.44%

👥 Company

Aurobindo Pharma Ltd

AUROPHARMA

Promoter Holding: %

Ahluwalia Contracts Ltd (AHLUCONT)

📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 944.50
% Change: 1.77% (Prev Close: 928.05)

Volume: 61,510
% Change: 93.79% (Prev Volume: 31,741)

Delivery: 49,130
Delivery % : 79.87
% Change: 153.17% (Prev Delivery: 19,406)

Turnover: 586 Lacs
% Change: 96.49% (Prev Turnover: 298)

💹 EOD Valuation

P/E Ratio: 28.45
P/B Ratio: 3.52
Market Cap: 6328 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: AHLUCONT
Market Cap: 6166 Rs. Cr.
Face Value: 2.00 Rs.

52 Week High: 1280.50
52 Week Low: 620.00

All-Time High: 1542.45 Rs.
All-Time Low: 15.15 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-0.76% | 5.96% | 34.96% | -17.31% | 30.85%

👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 55.32%

Change (3Y | 1Y): 0.00% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 12.44%

Change (3Y | 1Y): 0.16% | 0.37%

DII Holding

DII Holding: 24.26%

Change (3Y | 1Y): -3.26% | -0.07%

Public Holding: 7.98%

🏦 Financial Strength

Debt to Equity: 0.04
Debt: 76.13 Rs. Cr.

Book Value: 268.48 Rs.
Current Ratio: 2.12
Interest Coverage: 6.44
Free Cash Flow: 171.48 Rs. Cr.

📈 Growth & Sales

Sales Growth: 4.32%

Sales Growth Qtr (YOY | QoQ):
9.30% | -17.35%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
16.81% | 15.03% | 4.32%

💰 Profit & Earnings

Profit Growth %

Profit Growth: 3.86%

Profit Growth Qtr (YOY | QoQ):
67.57% | -38.55%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
25.72% | 9.08% | 3.86%

EPS Rs.

EPS (TTM): 33.20 Rs.

EPS Qtr (Last Year | Latest):
4.56 Rs. | 7.64 Rs.

EPS Annual (Last Annual | Annual March):
55.96 Rs. | 30.17 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
25.72% | 9.08%

Net Profit Rs. Cr.

Net Profit (TTM): 222.41 Rs. Cr.

Net Profit (Annual - March): 202.08 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
30.56| 83.33 | 51.21

EBITDA Rs. Cr.

EBITDA (Quarter): 102.24 Rs. Cr.
EBITDA (Previous Yr Ql): 71.19 Rs. Cr.

EBITDA (Annual - March): 397.75 Rs. Cr.
EBITDA (Previous Annual): 423.40 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
19.48% | 11.57%

📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 8.79%

OPM Qtr (Previous | Current):
10.17% | 8.59%

OPM Annual (5 Yrs | Last Yr | March):
9.34% | 10.06% | 8.34%

Return on Equity %

ROE: 11.89%

ROE (5 Yrs | 3 Yrs | Last Yr):
14.22% | 14.75% | 16.36%

Return on Capital Employed %

ROCE: 18.50%

ROCE (5 Yrs | 3 Yrs | Last Yr):
21.55% | 22.35% | 23.84%

Return on Assets %

ROA (TTM): 5.86%

ROA (5 Yrs | 3 Yrs | Last Yr):
6.82% | 7.50% | 8.13%

PEG Ratio: 3.05
Dividend Yield: 0.07%

PE 3 Yrs: 26.48
PE 5 Yrs: 25.92

Dividend Yield: 0.07%

👥 Company

Ahluwalia Contracts Ltd

AHLUCONT

Promoter Holding: %

AIA Engineering Ltd (AIAENG)

📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 3030.10
% Change: 0.33% (Prev Close: 3020.00)

Volume: 1,02,447
% Change: 361.89% (Prev Volume: 22,180)

Delivery: 87,763
Delivery % : 85.67
% Change: 565.73% (Prev Delivery: 13,183)

Turnover: 3,113 Lacs
% Change: 362.85% (Prev Turnover: 673)

💹 EOD Valuation

P/E Ratio: 25.84
P/B Ratio: 4.13
Market Cap: 28574 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: AIAENG
Market Cap: 28827 Rs. Cr.
Face Value: 2.00 Rs.

52 Week High: 4444.00
52 Week Low: 3000.60

All-Time High: 4949.95 Rs.
All-Time Low: 75.30 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-2.12% | -12.18% | -1.93% | -29.88% | 5.95%

👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 58.50%

Change (3Y | 1Y): 0.03% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 17.00%

Change (3Y | 1Y): -1.13% | -0.06%

DII Holding

DII Holding: 22.02%

Change (3Y | 1Y): 1.65% | -0.01%

Public Holding: 2.48%

🏦 Financial Strength

Debt to Equity: 0.07
Debt: 490.57 Rs. Cr.

Book Value: 734.41 Rs.
Current Ratio: 3.31
Interest Coverage: 65.51
Free Cash Flow: 1027.45 Rs. Cr.

📈 Growth & Sales

Sales Growth: -7.07%

Sales Growth Qtr (YOY | QoQ):
1.86% | -10.21%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
7.62% | 6.33% | -7.07%

💰 Profit & Earnings

Profit Growth %

Profit Growth: -1.48%

Profit Growth Qtr (YOY | QoQ):
17.51% | 6.95%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
13.23% | 19.18% | -1.48%

EPS Rs.

EPS (TTM): 117.28 Rs.

EPS Qtr (Last Year | Latest):
27.52 Rs. | 32.34 Rs.

EPS Annual (Last Annual | Annual March):
120.39 Rs. | 112.46 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
13.23% | 19.18%

Net Profit Rs. Cr.

Net Profit (TTM): 1105.84 Rs. Cr.

Net Profit (Annual - March): 1060.08 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
259.40| 285.35 | 305.17

EBITDA Rs. Cr.

EBITDA (Quarter): 420.40 Rs. Cr.
EBITDA (Previous Yr Ql): 372.31 Rs. Cr.

EBITDA (Annual - March): 1479.82 Rs. Cr.
EBITDA (Previous Annual): 1614.02 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
13.31% | 18.89%

📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 27.09%

OPM Qtr (Previous | Current):
26.07% | 29.49%

OPM Annual (5 Yrs | Last Yr | March):
25.01% | 27.61% | 26.91%

Return on Equity %

ROE: 15.42%

ROE (5 Yrs | 3 Yrs | Last Yr):
16.44% | 17.73% | 18.30%

Return on Capital Employed %

ROCE: 18.92%

ROCE (5 Yrs | 3 Yrs | Last Yr):
20.16% | 22.23% | 22.71%

Return on Assets %

ROA (TTM): 13.66%

ROA (5 Yrs | 3 Yrs | Last Yr):
14.43% | 15.83% | 16.02%

PEG Ratio: 1.36
Dividend Yield: 0.52%

PE 3 Yrs: 30.50
PE 5 Yrs: 30.90

Dividend Yield: 0.52%

👥 Company

AIA Engineering Ltd

AIAENG

Promoter Holding: %

Ajanta Pharmaceuticals Ltd (AJANTPHARM)

📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 2555.00
% Change: -0.87% (Prev Close: 2577.50)

Volume: 27,521
% Change: -18.63% (Prev Volume: 33,822)

Delivery: 15,209
Delivery % : 55.26
% Change: -2.58% (Prev Delivery: 15,612)

Turnover: 706 Lacs
% Change: -19.43% (Prev Turnover: 877)

💹 EOD Valuation

P/E Ratio: 34.32
P/B Ratio: 8.42
Market Cap: 31912 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: AJANTPHARM
Market Cap: 30954 Rs. Cr.
Face Value: 2.00 Rs.

52 Week High: 3485.75
52 Week Low: 2022.05

All-Time High: 3485.75 Rs.
All-Time Low: 4.03 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-2.97% | -0.54% | -0.21% | -20.81% | 23.85%

👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 66.26%

Change (3Y | 1Y): -4.22% | 0.00%

Pledged %: 14.43%

FII Holding

FII Holding: 8.86%

Change (3Y | 1Y): 0.56% | 0.00%

DII Holding

DII Holding: 17.50%

Change (3Y | 1Y): 5.04% | 0.02%

Public Holding: 7.38%

🏦 Financial Strength

Debt to Equity: 0.01
Debt: 47.42 Rs. Cr.

Book Value: 303.44 Rs.
Current Ratio: 2.41
Interest Coverage: 48.43
Free Cash Flow: 840.45 Rs. Cr.

📈 Growth & Sales

Sales Growth: 10.92%

Sales Growth Qtr (YOY | QoQ):
13.78% | 11.30%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
12.43% | 11.63% | 10.92%

💰 Profit & Earnings

Profit Growth %

Profit Growth: 8.92%

Profit Growth Qtr (YOY | QoQ):
3.89% | 13.35%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
14.26% | 8.71% | 8.92%

EPS Rs.

EPS (TTM): 74.45 Rs.

EPS Qtr (Last Year | Latest):
19.68 Rs. | 20.44 Rs.

EPS Annual (Last Annual | Annual March):
63.70 Rs. | 73.68 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
15.34% | 9.63%

Net Profit Rs. Cr.

Net Profit (TTM): 929.96 Rs. Cr.

Net Profit (Annual - March): 920.39 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
245.77| 225.26 | 255.34

EBITDA Rs. Cr.

EBITDA (Quarter): 377.68 Rs. Cr.
EBITDA (Previous Yr Ql): 356.82 Rs. Cr.

EBITDA (Annual - March): 1348.43 Rs. Cr.
EBITDA (Previous Annual): 1245.42 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
11.70% | 8.84%

📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 26.64%

OPM Qtr (Previous | Current):
25.39% | 26.97%

OPM Annual (5 Yrs | Last Yr | March):
27.53% | 27.85% | 27.30%

Return on Equity %

ROE: 24.91%

ROE (5 Yrs | 3 Yrs | Last Yr):
22.44% | 22.12% | 23.23%

Return on Capital Employed %

ROCE: 32.37%

ROCE (5 Yrs | 3 Yrs | Last Yr):
29.49% | 28.86% | 31.60%

Return on Assets %

ROA (TTM): 19.43%

ROA (5 Yrs | 3 Yrs | Last Yr):
17.60% | 17.00% | 17.74%

PEG Ratio: 3.82
Dividend Yield: 1.13%

PE 3 Yrs: 36.13
PE 5 Yrs: 28.31

Dividend Yield: 1.13%

👥 Company

Ajanta Pharmaceuticals Ltd

AJANTPHARM

Promoter Holding: %

Akums Drugs and Pharmaceuticals Ltd (AKUMS)

📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 461.60
% Change: -1.23% (Prev Close: 467.35)

Volume: 1,77,107
% Change: -32.72% (Prev Volume: 2,63,254)

Delivery: 1,21,750
Delivery % : 68.74
% Change: -23.64% (Prev Delivery: 1,59,445)

Turnover: 821 Lacs
% Change: -32.67% (Prev Turnover: 1,220)

💹 EOD Valuation

P/E Ratio: 21.27
P/B Ratio: 2.38
Market Cap: 7266 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: AKUMS
Market Cap: 7150 Rs. Cr.
Face Value: 2.00 Rs.

52 Week High: 949.00
52 Week Low: 405.00

All-Time High: 1175.90 Rs.
All-Time Low: 405.00 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-5.63% | -15.97% | -5.87% | -47.15% | 0.00%

👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 75.26%

Change (3Y | 1Y): 0.00% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 4.24%

Change (3Y | 1Y): 0.00% | -1.53%

DII Holding

DII Holding: 8.85%

Change (3Y | 1Y): 0.00% | 1.46%

Public Holding: 8.92%

🏦 Financial Strength

Debt to Equity: 0.03
Debt: 88.22 Rs. Cr.

Book Value: 193.59 Rs.
Current Ratio: 2.55
Interest Coverage: 8.53
Free Cash Flow: 201.44 Rs. Cr.

📈 Growth & Sales

Sales Growth: -2.47%

Sales Growth Qtr (YOY | QoQ):
0.48% | -2.99%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
11.27% | 3.90% | -2.47%

💰 Profit & Earnings

Profit Growth %

Profit Growth: 30.05%

Profit Growth Qtr (YOY | QoQ):
5.50% | -56.76%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
48.93% | 49.26% | 30.05%

EPS Rs.

EPS (TTM): 21.70 Rs.

EPS Qtr (Last Year | Latest):
4.08 Rs. | 4.03 Rs.

EPS Annual (Last Annual | Annual March):
-0.28 Rs. | 21.49 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
-42.93% | 37.55%

Net Profit Rs. Cr.

Net Profit (TTM): 347.27 Rs. Cr.

Net Profit (Annual - March): 343.78 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
61.21| 149.61 | 64.69

EBITDA Rs. Cr.

EBITDA (Quarter): 155.71 Rs. Cr.
EBITDA (Previous Yr Ql): 134.56 Rs. Cr.

EBITDA (Annual - March): 512.89 Rs. Cr.
EBITDA (Previous Annual): 157.18 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
20.55% | 112.21%

📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 11.29%

OPM Qtr (Previous | Current):
8.90% | 12.60%

OPM Annual (5 Yrs | Last Yr | March):
5.62% | 2.95% | 11.28%

Return on Equity %

ROE: 17.19%

ROE (5 Yrs | 3 Yrs | Last Yr):
6.53% | 13.14% | -2.90%

Return on Capital Employed %

ROCE: 16.20%

ROCE (5 Yrs | 3 Yrs | Last Yr):
8.96% | 13.66% | 2.40%

Return on Assets %

ROA (TTM): 8.64%

ROA (5 Yrs | 3 Yrs | Last Yr):
1.84% | 4.10% | -0.47%

PEG Ratio: 0.44
Dividend Yield: 0.00%

PE 3 Yrs: 46.82
PE 5 Yrs: 46.82

Dividend Yield: 0.00%

👥 Company

Akums Drugs and Pharmaceuticals Ltd

AKUMS

Promoter Holding: %